The Supreme Court recently ruled that generic drug makers cannot be sued on the grounds of adverse side effects if their product warning labels are the same as those from the brand-name manufacturers. The court overruled a multimillion dollar jury award to a woman in New Hampshire who was severely disfigured after taking a generic anti-inflammatory. In effect, the Supreme Court said the federal law trumps state law.

Poll Question:
Did the Supreme Court make the correct decision exempting generic drug companies from lawsuits?



No Opinion

Previous articleLigand Inks Week’s Second Lasofoxifene Licensing Deal
Next articleTransition Scores Rights to Develop Lilly Osteoarthritis Pain Drug